TWI561255B - Use of umirolimus and its derivatives for treating cancer - Google Patents

Use of umirolimus and its derivatives for treating cancer

Info

Publication number
TWI561255B
TWI561255B TW102144019A TW102144019A TWI561255B TW I561255 B TWI561255 B TW I561255B TW 102144019 A TW102144019 A TW 102144019A TW 102144019 A TW102144019 A TW 102144019A TW I561255 B TWI561255 B TW I561255B
Authority
TW
Taiwan
Prior art keywords
umirolimus
derivatives
treating cancer
cancer
treating
Prior art date
Application number
TW102144019A
Other languages
Chinese (zh)
Other versions
TW201521787A (en
Inventor
Ting Bin Yu
Shih Horng Su
Original Assignee
Manli Internat Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Manli Internat Ltd filed Critical Manli Internat Ltd
Priority to TW102144019A priority Critical patent/TWI561255B/en
Publication of TW201521787A publication Critical patent/TW201521787A/en
Application granted granted Critical
Publication of TWI561255B publication Critical patent/TWI561255B/en

Links

TW102144019A 2013-12-02 2013-12-02 Use of umirolimus and its derivatives for treating cancer TWI561255B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW102144019A TWI561255B (en) 2013-12-02 2013-12-02 Use of umirolimus and its derivatives for treating cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW102144019A TWI561255B (en) 2013-12-02 2013-12-02 Use of umirolimus and its derivatives for treating cancer

Publications (2)

Publication Number Publication Date
TW201521787A TW201521787A (en) 2015-06-16
TWI561255B true TWI561255B (en) 2016-12-11

Family

ID=53935295

Family Applications (1)

Application Number Title Priority Date Filing Date
TW102144019A TWI561255B (en) 2013-12-02 2013-12-02 Use of umirolimus and its derivatives for treating cancer

Country Status (1)

Country Link
TW (1) TWI561255B (en)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J liposome Res 2009; 19(4):322-331 Ind J Clin Biochem (Published online: 26 March 2013) 29(1):84-88 *

Also Published As

Publication number Publication date
TW201521787A (en) 2015-06-16

Similar Documents

Publication Publication Date Title
IL273090B (en) Methods and compositions for the treatment of cancer
IL245281A0 (en) Methods and compositions for treating cancer
IL242386B (en) Use of eribulin and lenvatinib as combination therapy for treatment of cancer
IL244353A0 (en) Compounds and use for treating cancer
SG11201508223YA (en) Treatment of cancer with dihydropyrazino-pyrazines
ZA201507733B (en) Treatment of cancer with dihydropyrazino-pyrazines
PT3060211T (en) Treatment of cancer and benign proliferative disorders
HK1213817A1 (en) Methods of treating cancer
HK1219513A1 (en) Methods of treating cancer
PL3065751T3 (en) Method for treatment of cancer and cancer comorbidities
HK1223547A1 (en) Methods for the treatment of cancer
GB201607581D0 (en) Treatment of cancer
HK1232118A1 (en) Treatment of cancer
HK1213475A1 (en) Combination of ro5503781, capecitabine and oxaliplantin for cancer therapy ro5503781
PL3016948T3 (en) 2-acylaminothiazoles for the treatment of cancer
EP2971044A4 (en) Compositions and methods for treating cancer
TWI561255B (en) Use of umirolimus and its derivatives for treating cancer
HK1214502A1 (en) Combination of ro5503781 and capecitabine for cancer therapy ro5503781
GB201322347D0 (en) Treatment of cancer
GB201318742D0 (en) Treatment of cancer
GB201322346D0 (en) Combination treatment of cancer
GB201308529D0 (en) Treatment of cancer
GB201305020D0 (en) Treatment of cancer
GB201317373D0 (en) Treatment and prevention of cancer
GB201322958D0 (en) Uses of oligouronates in cancer treatment